Kim, D.E.; Chang, B.Y.; Jeon, B.M.; Baek, J.I.; Kim, S.C.; Kim, S.Y.
SGL 121 Attenuates Nonalcoholic Fatty Liver Disease through Adjusting Lipid Metabolism Through AMPK Signaling Pathway. Int. J. Mol. Sci. 2020, 21, 4534.
https://doi.org/10.3390/ijms21124534
AMA Style
Kim DE, Chang BY, Jeon BM, Baek JI, Kim SC, Kim SY.
SGL 121 Attenuates Nonalcoholic Fatty Liver Disease through Adjusting Lipid Metabolism Through AMPK Signaling Pathway. International Journal of Molecular Sciences. 2020; 21(12):4534.
https://doi.org/10.3390/ijms21124534
Chicago/Turabian Style
Kim, Da Eun, Bo Yoon Chang, Byeong Min Jeon, Jong In Baek, Sun Chang Kim, and Sung Yeon Kim.
2020. "SGL 121 Attenuates Nonalcoholic Fatty Liver Disease through Adjusting Lipid Metabolism Through AMPK Signaling Pathway" International Journal of Molecular Sciences 21, no. 12: 4534.
https://doi.org/10.3390/ijms21124534
APA Style
Kim, D. E., Chang, B. Y., Jeon, B. M., Baek, J. I., Kim, S. C., & Kim, S. Y.
(2020). SGL 121 Attenuates Nonalcoholic Fatty Liver Disease through Adjusting Lipid Metabolism Through AMPK Signaling Pathway. International Journal of Molecular Sciences, 21(12), 4534.
https://doi.org/10.3390/ijms21124534